John Locke Foundation: Prudent Policy / Impeccable Research - Volume CCCI | Eastern NC Now

We will offer this allotment of three with more to come; some old, most new, but all quite informative, and, moreover, necessary to understanding that in North Carolina, there is a wiser path to govern ourselves and our People.

ENCNow
    Publisher's note: We want our readers to understand that there is wise policy afoot here in North Carolina, and to that end, we offer these excellent videos from our associates, in prudent policy research, at the John Locke Foundation.

    We will offer this allotment of three with more to come; some old, most new, but all quite informative, and, moreover, necessary to understanding that in North Carolina, there is a wiser path to govern ourselves and our People.


Carolina Journal’s Rick Henderson discusses A.G. Sessions’ approach to opioids



Rick Henderson, Carolina Journal editor-on-chief, discusses U.S. Attorney General Jeff Sessions’ recent trip to Raleigh to discuss the national opioid epidemic. Henderson offered these comments during an interview with Donna Martinez for Carolina Journal Radio.


N.C. FreeEnterprise Foundation’s Jonathan Kappler analyzes 2018 N.C. elections



Jonathan Kappler, executive director of the N.C. FreeEnterprise Foundation, previews 2018 N.C. elections. Kappler offered these comments during an interview for Carolina Journal Radio.


JLF’s Terry Stoops adjusts NEA national teacher pay rankings



Dr. Terry Stoops, John Locke Foundation vice president for research, explains why he adjusts teacher pay data from the National Education Association. Stoops offered these comments during an interview with Donna Martinez for Carolina Journal Radio.

Go Back

HbAD0

Latest Op-Ed & Politics

Spanberger signed HB167, the law that eliminated the tax exemption for various confederacy-linked groups
as RINO incumbents Cornyn in Texas and Cassidy in Louisiana trail in the polls

HbAD1

government's offer is rejected, the battle continues, no confidence vote in parliament

HbAD2

 
 
Back to Top